By 9 months after injection into 5X-MITRG AD mice, plaque-associated human microglia express numerous markers of disease-associated microglia (DAM) including CD9, TREM2 and APOE (Hasselmann et al., 2019). Here, TREM2 is linked to Alzheimer disease.